Stay updated with breaking news from Greg zante. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Consensus Recommendation of "Buy" from Analysts themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Brokerages Set Viking Therapeutics, Inc. (NASDAQ:VKTX) Target Price at $30.25 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Knights of Columbus Asset Advisors LLC raised its holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX – Free Report) by 3.1% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 40,557 shares of the biotechnology company’s stock after purchasing an additional 1,226 shares […] ....
Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Free Report) CFO Greg Zante sold 15,000 shares of Viking Therapeutics stock in a transaction on Thursday, January 4th. The stock was sold at an average price of $17.90, for a total transaction of $268,500.00. Following the completion of the transaction, the chief financial officer now directly owns 180,730 […] ....
Viking Therapeutics, Inc. (NASDAQ:VKTX) Q3 2023 Earnings Call Transcript October 25, 2023 Viking Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.23 EPS, expectations were $-0.22. Operator: Welcome to the Viking Therapeutics Third Quarter 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management’s prepared remarks, we […] ....